A study of a new formulation of lenacapavir that is designed to be used as a once-yearly intramuscular shot for prevention of HIV from sex. This multicenter study is fully enrolled and in follow up.
-
Filter
-
U
- All Projects
- Current
- Upcoming
- Past
- Multi-Country
-
Country +
- Angola
- Argentina
- Armenia
- Azerbaijan
- Bahrain
- Belarus
- Botswana
- Brazil
- Bronx
- Burkina Faso
- Burundi
- Cameroon
- Central Asia
- China
- Colombia
- Colombia and Peru
- Congo Brazzaville
- Cote d’ Ivoire
- Democratic Republic of the Congo
- Dominican Republic
- Egypt
- El Salvador
- Eswatini
- Eswatini CTU
- Ethiopia
- Georgia
- German
- Ghana
- Guatemala
- Haiti
- Harlem
- Honduras
- India
- Kazakhstan
- Kenya
- Kyrgyz Republic
- Kyrgyzstan
- Lesotho
- LesothoMalawi
- Liberia
- Malawi
- Mali
- Mauritania
- Mexico
- Moldova
- Mozambique
- Myanmar
- Namibia
- Nigeria
- Pakistan
- Panama
- Peru
- Philippines
- Russia
- Rwanda
- Senegal
- Sierra Leone
- South Africa
- South Sudan
- Tajikistan
- Tanzania
- Thailand
- turkmenistan
- Uganda
- Uganda Refugees
- Ukraine
- United States
- Uzbekistan
- Vietnam
- Zambia
- Zimbabwe
Status
Current
Locations
Our Approach
Research
Health Challenges
HIV/AIDS
Keywords
PrEP, HIV, CTU, prevention, Lenacapavir
